EmpowerPharm is delighted to announce the appointment of Ildiko Riss as Vice President of Quality & Regulatory Affairs.
Ildiko is an accomplished pharmaceutical executive with 30+ years of progressive experience and a strong portfolio of achievements. She has successfully led teams in different areas of pharmaceutical operations, including but not limited to pharmaceutical quality systems, scientific and technical affairs, analytical R&D, and quality control.
She has proven expertise in the development and commercialization of both prescription and non-prescription pharmaceutical dosage forms and in understanding related regulatory requirements. She has supported over 70 regulatory submissions (chemistry and manufacturing controls) to different regulatory bodies in her past, resulting in drug approval and commercialization. She has maintained site compliance, led regulatory audits, and just recently successfully guided her team to achieve EU GMP compliance for medicinal cannabis manufacturing, packaging, and testing.
Her previously held roles include pharmaceutical quality, regulatory, compliance, general management at ARA – Avanti Rx Analytics Inc., Contract Pharmaceuticals Limited, Dalton Pharma Services, Taro Pharmaceuticals Inc., and Novopharm Ltd.